Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1633–1656 of 4,721 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Signs and Symptoms, Respiratory Clear all

Conditions: Perinatal Stroke
Interventions: Magnetic Resonance Imaging, Behavioral Assessments, Non invasive Transcranial Magnetic Stimulation; Device · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 0 Years to 24 Months
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Danirixin, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 6
States / cities: Birmingham, Alabama • Denver, Colorado • Iowa City, Iowa + 3 more

Conditions: COVID-19-Induced Parosmia
Interventions: Stellate Ganglion Block, Placebo Sham Injection; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Lung Neoplasms, Carcinoma Non-small-cell Lung
Interventions: Multifocal Tissue Banking; Genetic
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Neoplasm Metastasis
Interventions: Cryoablation; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 8
States / cities: Los Angeles, California • Newnan, Georgia • Rochester, Minnesota + 4 more

Conditions: Post COVID-19 Condition, Post-COVID-19 Syndrome
Interventions: 6-Week Self-Management Group; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: COVID-19
Interventions: Self-prone position recommendation, Usual care; Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 12
States / cities: Long Beach, California • San Diego, California • Denver, Colorado + 9 more

Conditions: Chest Tube Removal
Interventions: Chest tube pull on inspiration, Expiration; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 342 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obstructive Sleep Apnea, Metabolic Syndrome X
Interventions: sleep disruption, sleep with and without positive pressure; Procedure
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Asthma, Bronchospasm, Shortness of Breath
Interventions: Virtual Teach to Goal, Brief Intervention; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 5 Years to 10 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma, Obesity, Obesity, Morbid, Bariatric Surgery Candidate
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Durham, North Carolina

Conditions: Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis
Interventions: Mometasone Furoate Nasal Irrigation, Mometasone Nasal Spray; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Portopulmonary Hypertension, Pulmonary Hypertension, Cirrhosis, Liver
Interventions: Ambrisentan Pill, Tadalafil Pill; Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Hypoxia
Interventions: Injectafer, Placebo; Drug · Other
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 18 Years to 40 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Natick, Massachusetts

Conditions: Cancer
Interventions: High-flow Oxygen, Low-flow Oxygen, High-flow Air, Low-flow Air; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthcare-Associated Pneumonia
Interventions: Oral Hygiene - teeth brushing; Other
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 8,709 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Cachexia
Interventions: GTx-024, Placebo; Drug
Lead sponsor: GTx; Industry
Eligibility: Not listed
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 50
States / cities: Anchorage, Alaska • Fayetteville, Arkansas • Corona, California + 41 more

Conditions: Multiple Sclerosis, Multiple Sclerosis-Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Interventions: Acute Intermittent Hypoxia, Sham-Acute Intermittent Hypoxia; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthcare-Associated Pneumonia, Sepsis
Interventions: antimicrobial initiation; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chronic Disease, Endocrine System Disease, Cardiovascular Disease, Respiratory Tract Disease, CNS Metabolic Disorders
Interventions: Observation; Other
Lead sponsor: Bracane Company; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Sevierville, Tennessee

Conditions: Vasculitis, Wegener's Granulomatosis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alpha 1-Antitrypsin Deficiency
Interventions: VX-634, Placebo; Drug
Lead sponsor: Vertex Pharmaceuticals Incorporated; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: Tempe, Arizona • Gainesville, Florida • Orlando, Florida + 2 more

Conditions: Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive
Interventions: Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin; Drug
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 1 Year to 12 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 54
States / cities: Birmingham, Alabama • Los Angeles, California • Oakland, California + 49 more

Conditions: Covid19
Interventions: rNAPc2, Heparin; Drug
Lead sponsor: ARCA Biopharma, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 11
States / cities: Fairhope, Alabama • Phoenix, Arizona • Tucson, Arizona + 8 more

Search by objective public record fields.

Baby Brain Recovery Study

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

Stellate Ganglion Block for COVID-induced Parosmia

A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing

Study of Cryoablation for Metastatic Lung Tumors

The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19

Awake Prone Position for Early Hypoxemia in COVID-19

Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal

Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress

Virtual Teach-to-Goal Education vs. Brief Education for Children

Contributing Factors in the Pathobiology of Airway Remodeling in Obesity

Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis

Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension

Intravenous Iron Effects on Performance at High Altitude

High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients

Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Intermittent Hypoxia in Persons With Multiple Sclerosis

Trial of Antimicrobial Restraint in Presumed Pneumonia

Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

A Phase 1, First-in-human Study of VX-634

Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19